Breast Cancer (Therapy)

Potential Therapy Could be Based on Breast Cancer Gene BRCA1

Published in Women's Health Weekly, March 11th, 1996

BRCA1, a gene that makes women susceptible to breast and ovarian cancer when it's defective, may be the starting point for a new cancer therapy.

Genetic immunization with a normal version of the gene destroyed human breast cancer tumors in two out of five mice and extended the lives of others with the disease, researchers report.

"I think it's a major step forward" toward developing a new therapy, said Dawn Willis, director of research communication at the American Cancer Society.

The experimental treatment involved injections of the gene BRCA1. Inherited susceptibility to breast and ovarian cancers is caused by a defective BRCA1...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry